Overview

ASPIRIN Trial Belgium

Status:
Recruiting
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether acetylsalicylic acid is effective on the recurrence and survival of colon cancer patients.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Antwerp
Collaborators:
Anticancerfund
Kom Op Tegen Kanker
Treatments:
Aspirin